HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$2.98
Day range
$2.91 - $3.11
Year range
$1.28 - $5.51
Market cap
242.47M USD
Avg Volume
138.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 268.00K | -48.56% |
Operating expense | 17.16M | 22.96% |
Net income | -39.40M | -24.35% |
Net profit margin | -14.70K | -141.75% |
Earnings per share | -0.46 | 16.78% |
EBITDA | -27.06M | 11.17% |
Effective tax rate | 2.16% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 172.74M | -45.25% |
Total assets | 360.69M | -25.87% |
Total liabilities | 175.94M | -4.28% |
Total equity | 184.75M | — |
Shares outstanding | 64.82M | — |
Price to book | 0.97 | — |
Return on assets | -20.19% | — |
Return on capital | -30.63% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -39.40M | -24.35% |
Cash from operations | -26.23M | -14.51% |
Cash from investing | 18.60M | 535.36% |
Cash from financing | -356.00K | -474.74% |
Net change in cash | -7.98M | 70.53% |
Free cash flow | -15.12M | 23.12% |
About
Founded
2018
Headquarters
Website
Employees
152